Antigens, receptors and dominant oncogenes and the prognosis of non-small cell lung cancer.
Stahel
R A
RA
Department of Medicine, University Hospital, Zurich, Switzerland.
D000017:ABO Blood-Group System; D015703:Antigens, CD / Q000032:analysis; D051927:CD24 Antigen; D002289:Carcinoma, Non-Small-Cell Lung / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D015816:Cell Adhesion Molecules, Neuronal / Q000032:analysis; D066246:ErbB Receptors / Q000032:analysis; D011905:Genes, ras; D006801:Humans; D008175:Lung Neoplasms / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D008562:Membrane Glycoproteins; D011379:Prognosis
D000017:ABO Blood-Group System; D015703:Antigens, CD; D051927:CD24 Antigen; C497889:CD24 protein, human; D015816:Cell Adhesion Molecules, Neuronal; D008562:Membrane Glycoproteins; D066246:ErbB Receptors